Latest filing published 13 Jan 2020 for Protara Therapeutics, Inc..
Insider track record
No signal scores available.
Opaleye, L.P.: trading record in brief
Opaleye, L.P. appears in our data through filings on Protara Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings, every one of them for a trade on 9 January 2020.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 January 2020 came the latest disclosure, a share grant in Protara Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Opaleye, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 777,635 sharesCommon StockSEC:0001209191-20-003219:0
- 1,426,234 shares@ US$7.01100.0% of flowCommon StockSEC:0001209191-20-003219:1
2 of 2 declarations
